top of page

Publications

Original Article

Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion

Cancer Vaccines

2006

Authors:

Zhang H, Knutson KL, Hellstrom KE, Disis ML, and Hellstrom I

Journal:

Molecular Cancer Therapeutics

Volume:

5(1)

Page:

149-55

Pubmed:

Original Article

Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers

General Immune Research

2006

Authors:

Benz CC, Fedele V, Xu F, Ylstra B, Ginzinger D, Yu M, Moore D, Kneuper-Hall D, Wolff DJ, Disis ML Eppenberger-Castori S, Eppenberger U, Schitulli F, Tommasi S, Paradiso A, Scott GK and Albertson D

Journal:

Genes Chromosomes Cancer

Volume:

45(11)

Page:

983-94

Pubmed:

Original Article

Immunoediting of cancers may lead to epithelial to mesenchymal transition

Cancer Vaccines

2006

Authors:

Knutson KL, Lu H, Stone B, Reiman JM, Behrens MD, Prosperi CM, Gad EA, Smorlesi A, and Disis ML

Journal:

Journal of Immunology

Volume:

177(3)

Page:

1526-33

Pubmed:

Original Article

Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer

Cancer Diagnostics

2006

Authors:

Goodell V, Salazar LG, Urban N, Drescher C, Gray H, Swensen R, McIntosh MW, and Disis ML

Journal:

Journal of Clinical Oncology

Volume:

24(5)

Page:

762-8

Pubmed:

Original Article

Human tumor cell lysates as a protein source for the detection of cancer antigen-specific humoral immunity

Cancer Diagnostics

2005

Authors:

Goodell, V, and Disis, M.L.

Journal:

Journal of Immunological Methods

Volume:

299(1-2)

Page:

129-138

Pubmed:

Original Article

Antimetastatic gene expression profiles mediated by retinoic acid receptor beta 2 in MDA-MB-435 breast cancer cells

General Immune Research

2005

Authors:

Wallden B, Edmond M, Swift ME, Disis ML and Swisshelm K

Journal:

BMC Cancer

Volume:

5

Page:

140

Pubmed:

Original Article

Clinical use of subcutaneous G-CSF or GM-CSF in malignancy

Cancer Vaccines

2005

Authors:

Disis ML

Journal:

Oncology

Volume:

19(4 Suppl 2)

Page:

5-9

Pubmed:

Original Article

Interleukin-7 improves reconstitution of antiviral CD4 T cells

T Cell Function & Therapy

2005

Authors:

Lu H, Zhao Z, Kalina T, Gillespy T, 3rd, Liggitt D, Andrews RG, Maloney DG, Kiem HP, and Storek J

Journal:

Clinical Immunology

Volume:

114(1)

Page:

30-41

Pubmed:

Original Article

Endogenous anti-HER2 antibodies block HER2 phosphorylation and signaling through extracellular signal-regulated kinase

Cancer Vaccines

2005

Authors:

Montgomery R., Makary E, Schiffman K, Goodell V, and Disis ML

Journal:

Cancer Research

Volume:

65(2)

Page:

650-6

Pubmed:

Original Article

Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells

Cancer Vaccines

2005

Authors:

Yang J, Huston L, Berger D, Danke NA, Liu AW, Disis ML and Kwok WW

Journal:

Journal of Clinical Oncology

Volume:

25(5)

Page:

428-36

Pubmed:

bottom of page